Arkansas Biotech Research Threatened With 20% Cut
In order to meet the higher priority needs of the state, the Arkansas Tobacco Settlement Commission should reduce its medical research funding by 20 percent, according to an independent report from the RAND Corp. Although the report praised the Arkansas Biosciences Institute for its success in attracting nearly $3 for every dollar of tobacco settlement money spent, it recommends that the commission reallocate 20 percent of its funding to programs aimed at reducing obesity, physical inactivity and cancer.